For the quarter ending 2025-12-31.
| Income Statement | 2025-12-31 | 2025-06-30 | ||
|---|---|---|---|---|
| Selling, general and administrative expenses | - | 2,142,522.25* | ||
| Amortization of intangible assets | 57,344 | 57,344.25* | ||
| Research and development expenses | 4,269,479 | 2,316,683.5* | ||
| General and administrative expenses | 1,935,482 | - | ||
| Total operating expenses | 6,262,305 | 4,516,550 | ||
| Loss from operations | -6,262,305 | -4,516,550* | ||
| Interest expense | 5,967 | - | ||
| Interest income | 198,797 | 213,257.25* | ||
| Interest expense | - | 83,180* | ||
| Change in fair value of derivative liabilities | - | 942.75* | ||
| Total other income, net | 192,830 | 131,020* | ||
| Net loss | -6,069,475 | -4,385,530* | ||
| Deemed dividend related to ratchet adjustment to warrants | - | 92,366.25* | ||
| Net loss attributable to common stockholders | - | -4,477,896.25* | ||
| Reclassification of unrealized gains on available-for-sale investments upon settlement | - | 0 | ||
| Total other comprehensive loss | - | 0* | ||
| Comprehensive loss | - | -4,477,896.25 | ||
| Basic EPS | -0.77 | -3.031 | ||
| Diluted EPS | -0.77 | -3.031 | ||
| Basic Average Shares | 7,920,795 | 1,477,372 | ||
| Diluted Average Shares | 7,920,795 | 1,477,372 | ||
BIOVIE INC. (BIVI)
BIOVIE INC. (BIVI)